Analyst Ratings for Edgewise Therapeutics (EWTX)
EWTX Rating Summary
EWTX Price Target Summary
- Highest: $66.00 (Raymond James)
- Lowest: $20.00 (Goldman Sachs)
- Average: $44.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$44.60 (+23.2%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 81%
Avg. $ Target:
$44.60 (+23.2%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 81%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/25/2025 | Goldman Sachs | Paul Choi | New Coverage | Neutral (N/A) |
20.00 (N/A) |
15.09 (36.21) |
139.96% | Details |
| 7/30/2025 | Raymond James » Updated 6/1/2026 |
Martin Auster | New Coverage | Strong Buy (N/A) |
66.00 (52.00) |
14.26 (36.21) |
153.93% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
